节点文献

3例糖皮质激素联合他克莫司治疗特发性膜性肾病的用药分析

Drug Use Analysis of Glucocorticoid Combined with Tacrolimus in the Treatment of 3 Cases of Idiopathic Membranous Nephropathy

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【作者】 胡丽玲王燕燕彭艳王珊珊

【Author】 Hu Liling;Wang Yanyan;Peng Yan;Wang Shanshan;The First College of Clinical Medical Science,China Three Gorges University;Department of Pharmacy,Yichang Central People’s Hospital;Office of Drug Clinical Trials,Yichang Central People’s Hospital;

【机构】 三峡大学第一临床医学院宜昌市中心人民医院药学部宜昌市中心人民医院药物临床试验办公室

【摘要】 目的:为临床药师参与特发性膜性肾病的治疗提供参考。方法:对临床药师参与的3例特发性膜性肾病的用药情况进行分析。结果:采用糖皮质激素联合他克莫司治疗特发性膜性肾病时,需把握药物的选择、剂量、疗程、给药时间、血药浓度、不良反应等,坚持有效性和安全性的统一。结论:临床药师参与特发性膜性肾病时,需密切关注患者用药合理性、依从性和药品不良反应。

【Abstract】 Objective: To provide reference for clinical pharmacists participating in the therapy of idiopathic membranous nephropathy patients. Methods: The drug use in 3 cases of idiopathic membranous nephropathy participated by clinical pharmacists was analyzed. Results: When idiopathic membranous nephropathy was treated with glucocorticoid combined with tacrolimus,it was necessary to master the drug selection,dose and blood concentration of the drugs,course and time of the treatment and adverse reactions etc. In addition,the effectiveness and safety should be unified. Conclusion: Clinical pharmacists should pay close attention to the rational drug use,compliance of patients and adverse reactions through participating in the therapy of idiopathic membranous nephropathy.

【基金】 湖北省自然科学基金项目(编号:2013CFB389)
  • 【分类号】R692
  • 【被引频次】11
  • 【下载频次】112
节点文献中: 

本文链接的文献网络图示:

本文的引文网络